Literature DB >> 8139603

Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.

G E Borodic1, R Ferrante, L B Pearce, K Smith.   

Abstract

Fiber diameter variability, acetylcholinesterase staining properties, and average fiber diameter were determined 5 weeks after varying doses of botulinum A toxin were administered into albino rabbit longissimus dorsi muscle. The average fiber diameter within the muscle appeared to be a function of the dose of botulinum toxin injected. Fiber diameter variability correlated with the dose of botulinum toxin administered. Both fiber diameter variability and acetylcholinesterase spread characteristics showed a distinct diffusion gradient over a defined field within a muscle. At lower doses (1 IU), collapse of the diffusion gradient occurred over a 15-30-mm segment of muscle. At higher doses (5-10 IU), diffusion of botulinum A toxin effect occurred throughout the entire muscle with no apparent end point. This study demonstrated that botulinum A toxin produces a gradient of denervation in a given muscle and that both the magnitude of denervation and the extent of the gradient are dose dependent. Furthermore, both muscle fiber diameter variability and acetylcholinesterase staining were useful as measures of chemodenervation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139603     DOI: 10.1002/mds.870090106

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  44 in total

1.  Localization of center of intramuscular nerve dense regions in adult anterior brachial muscles: a guide for botulinum toxin A injection to treat muscle spasticity.

Authors:  Shaohua Tang; Ming Xiaoming Zhang; Shengbo Yang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  [Botulinum toxin therapy in orthopaedics].

Authors:  L Döderlein
Journal:  Orthopade       Date:  2006-01       Impact factor: 1.087

3.  Muscle fiber orientation in muscles commonly injected with botulinum toxin: an anatomical pilot study.

Authors:  S Deshpande; M E Gormley; J R Carey
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 4.  Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Authors:  A S Schroeder; S Berweck; S H Lee; F Heinen
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

5.  Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs.

Authors:  A R Bentivoglio; A Fasano; T Ialongo; F Soleti; S Lo Fermo; A Albanese
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

6.  Localization of motor entry points and terminal intramuscular nerve endings of the musculocutaneous nerve to biceps and brachialis muscles.

Authors:  Je-Hun Lee; Hye-Won Kim; Sun Im; Xiaochun An; Mi-Sun Lee; U-Young Lee; Seung-Ho Han
Journal:  Surg Radiol Anat       Date:  2009-09-25       Impact factor: 1.246

7.  What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.

Authors:  W Poewe; G Deuschl; A Nebe; E Feifel; J Wissel; R Benecke; K R Kessler; A O Ceballos-Baumann; A Ohly; W Oertel; G Künig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

8.  Accuracy of non-guided versus ultrasound-guided injections in cervical muscles: a cadaver study.

Authors:  Alexandre Kreisler; Camille Gerrebout; Luc Defebvre; Xavier Demondion
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

9.  Intragastric injection of botulinum toxin A for the treatment of obesity.

Authors:  Reinhard Mittermair; Christian Keller; John Geibel
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

Review 10.  Spasticity treatment with botulinum toxins.

Authors:  A B Ward
Journal:  J Neural Transm (Vienna)       Date:  2008-04-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.